Albert D. Friesen | |
|---|---|
 | |
| Born | May 19, 1947 |
| Occupation(s) | President and CEO |
| Employer | Winnipeg Rh Institute |
| Known for | WinRho |
Albert "Bert" D. Friesen, OM (born May 19, 1947) is a Canadian biotechnologist involved in biotechnology innovation. [1] His biotechnology career began as the first full-time employee of the Winnipeg Rh Institute, where he later became president and CEO, and led the development of WinRho, one of Canada's first successful biotech products. [2]
Albert Friesen went to the University of Manitoba and earned a Ph.D. in protein chemistry. [3]
In 1987, Dr. Friesen was a founder and the company’s first board of directors Chairman at the Industrial Biotechnology Association of Canada (IBAC) which is now known as BIOTECanada. [4]
In 1997, Friesen founded Medicure, which sells a large number of cardiovascular products. In 2020, Medicure purchased Marley Drug and the company can now sell medications directly to patients. [4]
From 2014-2017, Friesen was chair on the International board of MEDA (Mennonite Economic Development Associates). [4]
In March 2023, Dr. Friesen was awarded Outstanding Leadership in Bioscience of the Year at the Annual Bioscience Association Manitoba (BAM) gala. [4]
The University of Manitoba is a public research university in Winnipeg, Manitoba, Canada. Founded in 1877, it is the first university of Western Canada. Both by total student enrolment and campus area, the University of Manitoba is the largest university in the province of Manitoba. Its main campus is located in the Fort Garry neighbourhood of Winnipeg, with other campuses throughout the city: the Bannatyne Campus, the James W. Burns Executive Education Centre, the William Norrie Centre, and the French-language affiliate, Université de Saint-Boniface in the Saint Boniface ward.
The University of Winnipeg is a public research university in Winnipeg, Manitoba, Canada. It offers undergraduate programs in art, business, economics, education, science and applied health as well as graduate programs. UWinnipeg's founding colleges were Manitoba College and Wesley College, which merged to form United College in 1938. The University of Winnipeg was established in 1967 when United College received its charter.
Gedeon Richter Plc. is a European multinational pharmaceutical and biotechnology company headquartered in Budapest. It is the largest pharmaceutical company in Central and Eastern Europe, with an expanding direct presence in Western Europe, China, Northern America and Latin America. Richter has the largest R&D unit in Central and Eastern Europe and operations in over 100 countries.
Palliser Furniture is a family-owned furniture manufacturing company headquartered in Winnipeg, Manitoba, Canada.
Cangene Corporation was a biopharmaceutical company based in Winnipeg, Manitoba, Canada. It was founded in 1984 and specialized in hyperimmunes, contract manufacturing, biopharmaceuticals and biodefense. Cangene was 61% owned by Canadian pharmaceutical giant Apotex and was publicly listed on the TSX under the symbol CNJ.
Albert Diamond Cohen, LLD was a Canadian entrepreneur, community builder, philanthropist, and Officer of the Order of Canada. He was Chairman, Co-President and Co-Chief Executive Officer of Gendis Inc., a Toronto Stock Exchange listed Canadian real estate and investment company headquartered in Winnipeg, Manitoba. At one time, Gendis held a 51% stake in Sony of Canada and owned the SAAN Stores retail chain.
Gail Sheryl Asper is a Canadian heiress, philanthropist, and corporate lawyer. Daughter of the media magnate Izzy Asper, she serves as the president and a trustee of the Asper Foundation.
UF Innovate | Accelerate @ Sid Martin Biotech is located in Alachua, Florida, in Progress Park. The program's mission is to foster the growth of bioscience startup companies that have some relationship to the university. The Incubator works with companies in all product areas relating to the life sciences, biomedical research, medicine, and chemical sciences.
Recipharm AB is one of the five largest pharmaceutical contract development and manufacturing organizations in the world, with production facilities in Sweden, France, Germany, Italy, Spain, Portugal, India and the UK as well as development sites in Sweden, Israel and the United States. The Swedish-based company employs around 5,200 people and operates over 18 facilities. The company provides pharmaceutical companies around the world with end-to-end development and manufacturing services, including a wide variety of dosage forms. Recipharm was listed on the Stockholm Stock Exchange in April 2014.
William E. Bentley is the Robert E. Fischell Distinguished Professor of Engineering, founding Director of the Fischell Institute for Biomedical Devices, and currently the Director of the Maryland Technology Enterprise Institute in the A. James Clark School of Engineering at the University of Maryland. He was previously the Chair of the Fischell Department of Bioengineering, where he assisted in establishing the department and provided leadership that led to its nationally ranked status.
BioMotiv is an accelerator company associated with The Harrington Project, an initiative centered at University Hospitals of Cleveland. Therapeutic opportunities were identified through relationships with The Harrington Discovery Institute, university and research institutions, disease foundations, and industry sources. Once opportunities are identified, BioMotiv oversees the development, funding, active management, and partnering of the therapeutic products.
Biotechnology in India is a sunrise sector within the Indian economy. Agencies of the Government of India concerned with the biotechnology industry include the Department of Biotechnology and the proposed Biotechnology Regulatory Authority of India. As of 2022, the sector is valued at $80 billion. Biotechnology in India is in a growth phase and the sector is expected to be valued at $150 billion by 2025 and surpass $300 billion in value by 2030.
The Biotechnology Innovation Organization (BIO) is the largest advocacy association in the world representing the biotechnology industry. It was founded in 1993 as the Biotechnology Industry Organization from a merger of the Industrial Biotechnology Association (IBA) and the Association of Biotechnology Companies (ABC), and changed its name to the Biotechnology Innovation Organization on January 4, 2016. Biotechnology Innovation Organization serves more than 1,100 biotechnology firms, research schools, state biotechnology centers and related associations in the United States and in more than 30 other countries.
Dr. Renu Swarup is an Indian geneticist and former Secretary, Government of India, formerly heading the Department of Biotechnology (DBT), Ministry of Science and Technology. She has actively contributed in the formulation of India's Biotechnology Vision and Strategy. She is credited with the establishment of India's largest microbial resource centre, Microbial Culture Collection.
For the American folk singer and songwriter, see Nancy Ames.
Albert Bourla is a Greek-American veterinarian and businessman known for serving as the chairman and chief executive officer of the pharmaceutical company Pfizer. He joined the company in 1993 and has held several executive roles across Pfizer's divisions. Prior to becoming chief executive officer, Bourla was chief operating officer.
John Maraganore is an American scientist, entrepreneur, and life sciences industry leader.
Rohit Srivastava is a Himanshu Patel Chair Professor in the Department of Biosciences and Bioegineering at IIT Bombay specialising in medical diagnostic devices, nanoengineered materials and photothermal cancer therapy. He was awarded the Shanti Swarup Bhatnagar Prize for Science and Technology in Medical Sciences in the year 2021 for his contributions to the development of affordable medical devices.
BIOTECanada, previously the Industrial Biotechnology Association of Canada, is a Canadian biotechnology industry association based in Ottawa, Ontario. It is an industry-funded membership organization composed of over 250 national and international pharmaceutical and gene therapy companies, medical device manufacturers, agricultural science businesses, law firms, academic institutions, research and development networks, advertising agencies, insurance companies and financial services firms.
   | This article about a Canadian scientist is a stub. You can help Wikipedia by expanding it. |
 | This biotechnology article is a stub. You can help Wikipedia by expanding it. |